Effects of depolarizing stimuli on calcium homeostasis in cultured rat motoneurones

British Journal of Pharmacology

Volumn 125, Issue 7, 1998, Pages 1421-1428

  Hubert, Jean Pierre ^a   Burgevin, Marie Claude ^a   Terro, Faraj ^b   Hugon, Jacques ^b   Doble, Adam ^a  

^a SANOFI   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

ALS; AMPA; Glutamic acid; Indo 1 AM; Intracellular calcium; Kainate; Motoneurone culture; NMDA; Riluzole; Veratridine

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR STIMULATING AGENT; AMPA RECEPTOR; CALCIUM ION; CHOLINE ACETYLTRANSFERASE; DIZOCILPINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; INDO 1; KAINIC ACID RECEPTOR; LANTHANUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT; NITRENDIPINE; RILUZOLE; VERATRIDINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; FEMALE; FLUOROMETRY; IMMUNOCYTOCHEMISTRY; MOTONEURON; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031736276     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702207     Document Type: Article

References (53)

1. BRORSON, J.R., MANZOLILLO, P.A., GIBBONS, S.J. & MILLER, R.J. (1995). AMPA receptor desensitisation predicts the selective vulnerability of cerehellar Purkinje cells to excitotoxicity. J. Neurosci., 15, 4515-4524.
2. BRYSON, H., FULTON, B. & BENFIELD, P. (1996). Riluzole: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs, 52, 549-563.
3. BURGARD, E.G. & HABLITZ, J.J. (1995). N-Methyl-D-aspartate receptor-mediated calcium accumulation in neocortical neurons. Neuroscience, 69, 351-362.
4. CARRIEDO, S.G., YIN, H.Z. & WEISS, J.H. (1996). Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci., 16, 4069-4079.
5. CHOI, D.W. (1988a). Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623-634.
6. CHOI, D.W. (1988b). Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischémie damage. Trends Neurosci., 11, 465-469.
7. COURATIER, P., HUGON, J., SINDOU, P., VALLAT, J.M. & DUMAS, M. (1993). Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet, 341, 265-268.
8. DEBONO, M.W., LE GUERN, J., CANTON, T., DOBLE, A. & PRADIER, L. (1993). Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol., 235, 283-289.
9. DOBLE, A. (1996). The pharmacology and mechanism of action of riluzole. Neurology, 47, S233-S241.
10. DORHMANN, U., EDGAR, D., SENDTNER, M. & THOENEN, H. (1986). Muscle-derived factors that support survival and promote fiber outgrowth from embryonic chick spinal motor neurons in culture. Dev. Biol., 118, 209-221.
11. ESTEVEZ, A.G., STUTZMANN, J.M. & BARBEITO, L. (1995). Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur. J. Pharmicol., 280, 47-53.
12. GALLO, V., CIOTTI, M.T., COLETTI, A., ALOSI, F. & LEVY, G. (1982). Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. U.S.A., 79, 7919-7923.
13. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron, 15, 193-204.
14. GROSMAN, D.D., LORENZI, M.V., TRINIDAD, A.C. & STRAUSS, W.L. (1995). The human choline acetyltransferase gene encodes two proteins. J. Neurochem., 65, 484-491.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
16. HENDERSON, C.E., HUCHET, M. & CHANGEUX, J. (1983). Denervation increases a neurite-promoting activity in extracts of skeletal muscle. Nature, 302, 609-611.
17. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science, 252, 851-853.
18. HUBERT, J.P., DELUMEAU, J.C., PREMONT, J., DOBLE, A. & GLOWINSKI, J. (1992). Mobilisation du calcium intracellulaire dans des neurones de mésencéphale de rat en culture induite par une dépolarisation. Antagonisme par le riluzole. Colloque de la Société des Neurosciences, 83, A79.
19. HUBERT, J.P., DELUMEAU, J.C., PREMONT, J., GLOWINSKI, J. & DOBLE, A. (1994). Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br. J. Pharmacol., 113, 261-267.
20. HNO, M., OZAWA, S. & TSUZUKI, K. (1990). Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J. Physiol., 424, 151-165.
21. INCE, P.G., STOUT, N., SHAW, P.J., SLADE, J., HUNZIKER, W., HEIZMANN, C. & BAINBRIDGE, K.G. (1993). Parvalbumin and calbindin D-28 K in the human motor system and in motor neurone disease. Neuropathol. Appl. Neurobiol., 19, 291-299.
22. KOCH, R.A. & BARISH, M.E. (1994). Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J. Neurosci., 14, 2585-2593.
23. 2+ concentration in isolated hippocampal neurones. Br. J. Pharmacol., 89, 191-198.
24. LIMBRlCK, D.D., CHURN, S.B., SOMBATI, S. & DELORENZO, R.J. (1995). Inability to restore resting intracellular calcium levels as an early indicator of delayed neuronal cell death. Brain Res., 690, 145-156.
25. LIPTON, S.A. & ROSENBERG, P.A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med., 330, 613-622.
26. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J., 3, 2519-2526.
27. MICHAELS, R.L. & ROTHMAN, S.M. (1990). Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J. Neurosci., 10, 283-292.
28. 2+ release. Trends Pharmacol. Sci., 16, 356-359.
29. MURPHY, S.N. & MILLER, R.J. (1988). A glutamate receptor regulates Ca2+ mobilization in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A., 85, 8737-8741.
30. ++ influx into striatal neurons by kainic acid. J. Pharmacol. Exp. Therap., 249, 184-193.
31. MURPHY, S.N., THAYER, S.A. & MILLER, R.J. (1987). The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro. J. Neurosci., 7, 4145-4158.
32. OLNEY, J.W. (1978). Neurotoxicity of excitatory amino acids. In Kainic acid as a tool in neurobiology. ed. McGeer, E.G., Olney, J.W. & McGeer, P.L., pp. 95-121. New York: Raven Press.
33. PARKS, T.N., ARTMAN, L.D., ALASTI, N. & NEMETH, E.F. (1991). Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells. Brain Res., 552, 13-22.
34. PERRY, T.L., HANSEN, S. & JONES, K. (1987). Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology, 37, 1845-1848.
35. PLAITAKIS, A. & CARASCIO, J.T. (1987). Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol., 22, 575-579.
36. PLAITAKIS, A., FESDJIAN, C.O. & SHASHIDHARAN, P. (1996). Glutamate antagonists in amyotrophic lateral sclerosis: a review of their therapeutic potential. CNS Drugs, 5, 437-456.
37. PRUSS, R.M., AKESON, R.L., RACKE, M.M. & WILBURN, J.L. (1991). Agonist-activated cobalt uptake identifies divalent cation permeable kainate receptors on neurons and glia. Neuron, 7, 509-519.
38. REGAN, R.F. (1996). The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci. Lett., 213, 9-12.
39. ROTHSTEIN, J.D. (1995). Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv. Neurol., 68, 7-20.
40. ROTHSTEIN, J.D., JIN, L., DYKES-HOBERG, M. & KUNCL, R.W. (1993). Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6591-6595.
41. ROTHSTEIN, J.D. & KUNCL, R.W. (1995). Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem., 65, 643-651.
42. ROTHSTEIN, J.D., MARTIN, L.J. & KUNCL, R.W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engt. J. Med., 326, 1464-1468.
43. ROTHSTEIN, J.D., TSAI, G., KUNCL, R.W., CLAWSON, L., CORNBLATH, D.R., DRACHMAN, D.B., PESTRONK, A., STAUCH, B.L. & COYLE, J.T. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol., 28, 18-35.
44. ROTHSTEIN, J.D., VAN KAMMEN, M., LEVEY, A.I., MARTIN, L.J. & KUNCL, R.W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol., 38, 73-84.
45. SHAW, P.J. (1994). Excitotoxicity and motor neurone disease: a review of the evidence. J. Neurol. Sci., 124, (Suppl), 6-13.
46. SHAW, P.J. & INCE, P.G. (1997). Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol., 244, (Suppl 2), S3-S14.
47. SKEEN, G.A., TWYMAN, R.E. & WHITE, H. (1993). The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmocal., 44, 443-450.
48. TÖLLE, T.R., BERTHELE, A., ZIEGELGÄNSBERGER, W., SEEBURG, P.H. & WISDEN, W. (1993). The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neuroasci., 13, 5009-5028.
49. 2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated injury. Neurobiol. Dis., 1, 101-110.
50. WEISS, J.H., HARTLEY, D.M., KOH, J. & CHOI, D.W. (1990). The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science, 247, 1474-1477.
51. WILLIAMS, D.B. & WINDEBANK, A.J. (1991). Motor neuron disease (amyotrophic lateral sclerosis). Mayo. Clin. Proc., 66, 54-82.
52. WILLIAMS, T.L., DAY, N.C., INCE, P.G., KAMBOJ, R.K. & SHAW, P. (1997). Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol., 42, 200-207.
53. WOKKE, J. (1996). Riluzole. Lancet, 348, 795-799.